These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 25043151)
1. Characterization of the enterovirus 71 VP1 protein as a vaccine candidate. Zhou SL; Ying XL; Han X; Sun XX; Jin Q; Yang F J Med Virol; 2015 Feb; 87(2):256-62. PubMed ID: 25043151 [TBL] [Abstract][Full Text] [Related]
2. Characterization of the enterovirus 71 P1 polyprotein expressed in Pichia pastor as a candidate vaccine. Han X; Ying XL; Zhou SL; Han T; Huang H; Jin Q; Yang F; Sun QY; Sun XX Hum Vaccin Immunother; 2014; 10(8):2220-6. PubMed ID: 25424925 [TBL] [Abstract][Full Text] [Related]
3. Production of EV71 vaccine candidates. Chong P; Hsieh SY; Liu CC; Chou AH; Chang JY; Wu SC; Liu SJ; Chow YH; Su IJ; Klein M Hum Vaccin Immunother; 2012 Dec; 8(12):1775-83. PubMed ID: 22992566 [TBL] [Abstract][Full Text] [Related]
4. Oral immunization of mice using Bifidobacterium longum expressing VP1 protein from enterovirus 71. Yu Z; Huang Z; Sao C; Huang Y; Zhang F; Ma G; Chen Z; Zeng Z; Qiwen D; Zeng W Arch Virol; 2013 May; 158(5):1071-7. PubMed ID: 23275129 [TBL] [Abstract][Full Text] [Related]
5. Pros and cons of VP1-specific maternal IgG for the protection of Enterovirus 71 infection. Kim YI; Song JH; Kwon BE; Kim HN; Seo MD; Park K; Lee S; Yeo SG; Kweon MN; Ko HJ; Chang SY Vaccine; 2015 Nov; 33(48):6604-10. PubMed ID: 26529069 [TBL] [Abstract][Full Text] [Related]
6. Similar protective immunity induced by an inactivated enterovirus 71 (EV71) vaccine in neonatal rhesus macaques and children. Zhang Y; Wang L; Liao Y; Liu L; Ma K; Yang E; Wang J; Che Y; Jiang L; Pu J; Guo L; Feng M; Liang Y; Cui W; Yang H; Li Q Vaccine; 2015 Nov; 33(46):6290-7. PubMed ID: 26419198 [TBL] [Abstract][Full Text] [Related]
7. Recombinant VP1 protein expressed in Pichia pastoris induces protective immune responses against EV71 in mice. Wang M; Jiang S; Wang Y Biochem Biophys Res Commun; 2013 Jan; 430(1):387-93. PubMed ID: 23159634 [TBL] [Abstract][Full Text] [Related]
8. Induction of protective immune responses against EV71 in mice by baculovirus encoding a novel expression cassette for capsid protein VP1. Premanand B; Kiener TK; Meng T; Tan YR; Jia Q; Chow VT; Kwang J Antiviral Res; 2012 Sep; 95(3):311-5. PubMed ID: 22691220 [TBL] [Abstract][Full Text] [Related]
9. Oral immunization with recombinant enterovirus 71 VP1 formulated with chitosan protects mice against lethal challenge. Zhang F; Hao C; Zhang S; Li A; Zhang Q; Wu W; Liu L; Li C; Liang M; Li X; Li D Virol J; 2014 May; 11():80. PubMed ID: 24885121 [TBL] [Abstract][Full Text] [Related]
10. Induction of a high-titered antibody response using HIV gag-EV71 VP1-based virus-like particles with the capacity to protect newborn mice challenged with a lethal dose of enterovirus 71. Wang X; Dong K; Long M; Lin F; Gao Z; Wang L; Zhang Z; Chen X; Dai Y; Wang H; Zhang H Arch Virol; 2018 Jul; 163(7):1851-1861. PubMed ID: 29582164 [TBL] [Abstract][Full Text] [Related]
11. Hexon-modified recombinant E1-deleted adenoviral vectors as bivalent vaccine carriers for Coxsackievirus A16 and Enterovirus 71. Zhang C; Yang Y; Chi Y; Yin J; Yan L; Ku Z; Liu Q; Huang Z; Zhou D Vaccine; 2015 Sep; 33(39):5087-94. PubMed ID: 26296491 [TBL] [Abstract][Full Text] [Related]
12. VP1 of Enterovirus 71 Protects Mice Against Enterovirus 71 and Coxsackievirus B3 in Lethal Challenge Experiment. Chen FH; Liu X; Fang HL; Nan N; Li Z; Ning NZ; Luo DY; Li T; Wang H Front Immunol; 2019; 10():2564. PubMed ID: 31787970 [TBL] [Abstract][Full Text] [Related]
13. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease. Lyu K; He YL; Li HY; Chen R J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050 [TBL] [Abstract][Full Text] [Related]
14. Recombinant baculovirus associated with bilosomes as an oral vaccine candidate against HEV71 infection in mice. Premanand B; Prabakaran M; Kiener TK; Kwang J PLoS One; 2013; 8(2):e55536. PubMed ID: 23390538 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice. Huo C; Yang J; Lei L; Qiao L; Xin J; Pan Z Vaccine; 2017 Dec; 35(52):7322-7330. PubMed ID: 29129453 [TBL] [Abstract][Full Text] [Related]
16. Antigenicity, animal protective effect and genetic characteristics of candidate vaccine strains of enterovirus 71. Mao Q; Li N; Yu X; Yao X; Li F; Lu F; Zhuang H; Liang Z; Wang J Arch Virol; 2012 Jan; 157(1):37-41. PubMed ID: 21984267 [TBL] [Abstract][Full Text] [Related]
17. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice. Yang L; Liu Y; Li S; Zhao H; Lin Q; Yu H; Huang X; Zheng Q; Cheng T; Xia N Vaccine; 2016 Nov; 34(48):5938-5945. PubMed ID: 27771182 [TBL] [Abstract][Full Text] [Related]
18. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Chung YC; Ho MS; Wu JC; Chen WJ; Huang JH; Chou ST; Hu YC Vaccine; 2008 Mar; 26(15):1855-62. PubMed ID: 18329759 [TBL] [Abstract][Full Text] [Related]
19. EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge. Wang X; Xiao X; Zhao M; Liu W; Pang L; Sun X; Cen S; Yang BB; Huang Y; Sheng W; Zeng Y BMC Res Notes; 2016 Jan; 9():42. PubMed ID: 26809443 [TBL] [Abstract][Full Text] [Related]
20. Protective effect of enterovirus‑71 (EV71) virus‑like particle vaccine against lethal EV71 infection in a neonatal mouse model. Cao L; Mao F; Pang Z; Yi Y; Qiu F; Tian R; Meng Q; Jia Z; Bi S Mol Med Rep; 2015 Aug; 12(2):2473-80. PubMed ID: 25936344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]